ACOG says no to hormone therapy for heart disease prevention

05/24/2013 | PhysiciansBriefing.com

The American College of Obstetricians and Gynecologists issued a committee opinion advising against the use of menopausal hormone therapy for primary or secondary prevention of coronary heart disease. The group said there is not enough evidence linking long-term estrogen treatment or hormone therapy to improved cardiovascular outcomes. "As with younger women, use of hormone therapy and estrogen therapy should be individualized based on each woman's risk-benefit ratio and clinical presentation," ACOG said in the journal Obstetrics & Gynecology.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR